The global ovarian cancer diagnostics and therapeutics market was valued at USD 2.90 Billion in 2024 and is projected to reach USD 6.50 Billion by 2034, growing at a CAGR of 8.40% during 2025–2034. Key growth drivers include rising global incidence of ovarian cancer, advancements in targeted therapies, and the evolution of early detection technologies. The report provides insights int... https://www.expertmarketresearch.com/reports/ovarian-cancer-diagnostics-and-therapeutics-market